Home›Compare›Noom vs SnagRx

Noom vs SnagRx: Which Is Better?

Head-to-head comparison of Noom and SnagRx based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Noom scores higher overall in our independent evaluation (59.8/100 vs 54.8/100), leading on trust & safety, experience, reputation. SnagRx comes out ahead on value, product range.

60
Noom
Fair

Psychology-driven digital weight management platform combining behavioral coaching with GLP-1 medication prescribing, valued at $3.7B.

Visit Noom
55
SnagRx
Below Average

SnagRx is a 2026 compounded-GLP-1 storefront run by Modern Metabolic Medicine, Inc., which also operates Embody and RodeoMeds. It sells semaglutide from $69/mo and tirzepatide from $119/mo on 12-month prepay.

Visit SnagRx

Score Breakdown

DimensionNoomSnagRx
Overall Score59.8/100 ✓54.8/100
Trust & Safety30%65/100 ✓50/100
Value25%60/10085/100 ✓
Experience20%70/100 ✓45/100
Product Range15%35/10040/100 ✓
Reputation10%60/100 ✓35/100

At a Glance

Founded20082026
HeadquartersPrinceton, NJWilmington, DE
Publicly tradedNoNo
Treatment categories21
Treatments listed82
Starting price$17/mo$69/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryNoomSnagRx
Weight Loss / GLP-1$17–$43
Noom Weight (Behavioral Only)
$69–$99
Compounded Semaglutide

Noom

+Best-in-class behavioral change platform with published clinical backing and 4.7-star App Store rating
+Multiple GLP-1 price tiers including unique microdose program from $49/mo
+Strong brand recognition: $3.7B valuation, 18 years of operation, backed by Sequoia/Silver Lake
−$56M class action settlement over autorenewal/cancellation practices; BBB 'D' rating with 1,200+ complaints
−Coaching quality criticized as automated/templated rather than personalized
−Microdose tiers are priced per-plan rather than flat, so the advertised low price is not the price most patients pay
Read the full Noom review →

SnagRx

+Among the lowest compounded GLP-1 prices we track: semaglutide $69–99/mo and tirzepatide $119–149/mo, flat across doses, no membership fee
+Names four dispensing pharmacies and its prescriber network (OpenLoop Health)
+Consult, supplies and 1–2 day temperature-controlled shipping included
−Multi-month plans are non-refundable in whole and in part; reviewers say the $69/mo headline was not clear as a $828 upfront charge
−Parent company's shared BBB profile (SnagRx, Embody, RodeoMeds) is rated C with 72 complaints; the common ownership is not disclosed on the storefronts
−Claims 125,000+ customers but has only a handful of Trustpilot reviews (3.1/5), citing 19-day fulfillment delays
Read the full SnagRx review →

Noom vs SnagRx — FAQ

Is Noom better than SnagRx?

▾

Noom scores higher overall in our independent evaluation (59.8/100 vs 54.8/100), leading on trust & safety, experience, reputation. SnagRx comes out ahead on value, product range.

Is Noom or SnagRx cheaper?

▾

Noom has the lower starting price (from $17/mo vs $69/mo for SnagRx). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Noom and SnagRx both offer?

▾

Both platforms treat Weight Loss / GLP-1. Noom covers 2 treatment categories total and SnagRx covers 1.

Still deciding?